The Aim of This Study is to Investigate the Persistence of Antibody Response in Adults up to 15 Years After One Booster Dose of GlaxoSmithKline (GSK) Biologicals' Encepur Adults Vaccine
Clinical trial NCT03294135 · COMPLETED
Trial details
- NCT number
- NCT03294135
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-05
- Primary completion
- 2021-10-25
- Enrollment
- 194
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.